Related Experiment Video
Updated: May 12, 2026
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
HER2/neu and Ki-67 as prognostic biomarkers in urothelial carcinoma
Anamika Rawat1, Himanshu Joshi2, Nishant Mitra3
1Department of Pathology, Kalyan Singh Government Medical College, Bulandshahr, Uttar Pradesh, India.
Abstract:
The prognostic significance of Her2/neu and Ki-67 expression remains insufficiently defined in urothelial carcinoma even though it constitutes a major proportion of malignancies in the male population of the United States and India. Therefore, it is of interest to evaluate Immunohistochemical (IHC) expression of HER2/neu and Ki-67 to correlate with clinicopathological parameters in thirty histologically confirmed cases of urothelial carcinoma in an Indian cohort. We show that the overexpression of HER2/neu and Ki-67 correlates positively with higher tumor grade, advanced stage and may serve as reliable prognostic biomarkers thus guiding therapeutic decision making in management of urothelial carcinoma.